Best Medical Stocks To Buy Right Now

Icon Plc (NASDAQ:ICLR) – Stock analysts at KeyCorp issued their Q1 2019 EPS estimates for shares of Icon in a report issued on Monday, September 10th. KeyCorp analyst D. Hooker expects that the medical research company will post earnings of $1.66 per share for the quarter. KeyCorp currently has a “Overweight” rating and a $157.00 target price on the stock. KeyCorp also issued estimates for Icon’s Q2 2019 earnings at $1.72 EPS, Q3 2019 earnings at $1.78 EPS and Q4 2019 earnings at $1.84 EPS.

Get Icon alerts:

Other equities research analysts also recently issued research reports about the company. Jefferies Financial Group lifted their target price on Icon to $150.00 and gave the stock a “buy” rating in a report on Friday, June 1st. BidaskClub upgraded Icon from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. Robert W. Baird restated a “buy” rating and issued a $154.00 price objective on shares of Icon in a research report on Thursday, July 26th. SunTrust Banks boosted their price objective on Icon to $153.00 and gave the company a “buy” rating in a research report on Thursday, July 26th. Finally, Zacks Investment Research upgraded Icon from a “hold” rating to a “buy” rating and set a $147.00 price objective for the company in a research report on Thursday, July 5th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $146.22.

Best Medical Stocks To Buy Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Brink’s (NYSE:BCO) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Sean Williams]

    Even though marijuana is on its way to becoming legal in Canada and it’s been given the thumbs-up for medical purposes in 30 U.S. states, this is still very much a cash business. Federal scheduling in the U.S. ensures that access to lines of credit, loans, and even a basic checking account are few and far between. Meanwhile, in Canada, only recently have banks been given the OK to work strategically with marijuana businesses. This opens the door for armored truck and ATM service companies like Brink’s Company (NYSE:BCO) to succeed.

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Max Byerly]

    Shares of Brink’s (NYSE:BCO) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $99.50.

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Average taking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

Best Medical Stocks To Buy Right Now: Noble Energy Inc.(NBL)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Noble Midstream (NYSE:NBLX) has a bold plan to grow its already impressive 7.4%-yielding distribution to investors by 20% per year all the way through 2022, which is one of the fastest rates in the midstream sector. Driving that growth would be the expansion of the company’s oil and gas gathering system to support the anticipated increase in production from customers like its parent, Noble Energy (NYSE:NBL).

  • [By Matthew DiLallo]

    Fueling that forecast is the company’s ability to expand its midstream footprint to support the growth of its customers, including its parent Noble Energy (NYSE:NBL). The company operates several gathering systems in both the Permian Basin and DJ Basin that it expects to continue expanding as customers drill more wells.

  • [By Dan Caplinger]

    Yet along with those gains has come continued volatility, and even among the biggest companies in the market, some have faced substantial setbacks that have caused their shares to fall 15% or more in August. As of today, Hanesbrands (NYSE:HBI), Dentsply Sirona (NASDAQ:XRAY), and Noble Energy (NYSE:NBL) have been the worst-performing members of the S&P 500 so far this month, and below, you’ll learn more about how they got there and what’s ahead for their respective businesses.

Best Medical Stocks To Buy Right Now: Materialise NV(MTLS)

Advisors’ Opinion:

  • [By Logan Wallace]

    TheStreet upgraded shares of Materialise (NASDAQ:MTLS) from a c+ rating to a b- rating in a research report report published on Thursday.

    Several other brokerages have also commented on MTLS. BidaskClub upgraded shares of Materialise from a sell rating to a hold rating in a report on Tuesday, August 28th. ValuEngine upgraded shares of Materialise from a hold rating to a buy rating in a report on Friday, August 24th. Finally, Zacks Investment Research lowered shares of Materialise from a hold rating to a strong sell rating in a report on Thursday, August 9th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of Hold and an average target price of $19.00.

  • [By Joseph Griffin]

    Blackline (NASDAQ: MTLS) and Materialise (NASDAQ:MTLS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Navigator (NYSE:NVGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Royal Caribbean Cruises (NYSE:RCL) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Buy Right Now: First Busey Corporation(BUSE)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of First Busey Co. (NASDAQ:BUSE) hit a new 52-week high and low during trading on Monday . The company traded as low as $33.22 and last traded at $32.70, with a volume of 1006 shares traded. The stock had previously closed at $33.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on First Busey (BUSE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of First Busey Co. (NASDAQ:BUSE) during the 1st quarter, Holdings Channel reports. The firm bought 7,000 shares of the bank’s stock, valued at approximately $208,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on First Busey (BUSE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Buy Right Now: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In other news, after a week, shares of T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) are lower than they were before they announced a merger deal. The Fools discuss the likelihood of the plan making it past regulators and shareholders to closing, and consider whether it would be a win or a loss for customers.

  • [By ]

    Of course T-Mobile (TMUS) and Sprint (S) have reportedly restarted merger talks, joining forces to take on Verizon (VZ) and AT&T (T) makes perfect sense.

  • [By Adam Levy]

    T-Mobile (NASDAQ:TMUS) has been looking to get into video distribution since its Layer3 TV acquisition in December 2017. The company initially planned to launch a pay-TV service by the end of 2018, but it’s pushed back those plans to the first half of 2019.

  • [By ]

    After years of on-again, off-again talks, Sprint (S) and T-Mobile (TMUS)  finally announced a merger Sunday.

    Sprint investors will receive 0.10256 shares of T-Mobile for each share of Sprint. Based on T-Mobile’s close at $64.52 on Friday, the deal values Sprint at $6.62 per share. Including assumed debt, the deal values Sprint at about $59 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *